Breast cancer in patients with Li–Fraumeni syndrome – a case-series study and review of literature

References

• de BruinMAFordJMKurianAWA young woman with bilateral breast cancer: identifying a genetic cause and implications for managementJ Natl Compr Canc Netw201311551251723667202
   PubMed Web of Science ®Google Scholar
• DamineniSRaoVRKumarSGermline mutations of TP53 gene in breast cancerTumour Biol20143599219922724929325
   PubMedGoogle Scholar
• XuJQianJHuYHeterogeneity of Li-Fraumeni syndrome links to unequal gain-of-function effects of p53 mutationsSci Rep20144422324573247
   PubMed Web of Science ®Google Scholar
• ChompretABrugieresLRonsinMP53 germline mutations in childhood cancers and cancer risk for carrier individualsBr J Cancer200082121932193710864200
   PubMed Web of Science ®Google Scholar
• LiFPFraumeniJFJrRhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndromeJ Natl Cancer Inst1969436136513735396222
   PubMedGoogle Scholar
• LiFPFraumeniJFJrMulvihillJJA cancer family syndrome in twenty-four kindredsCancer Res19884818535853623409256
   PubMed Web of Science ®Google Scholar
• MalkinDLiFPStrongLCGerm line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasmsScience19902504985123312381978757
   PubMed Web of Science ®Google Scholar
• WuCCKraheRLozanoGJoint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndromeHum Genet2011129666367321305319
   PubMed Web of Science ®Google Scholar
• YaoZSherifZAThe effect of epigenetic silencing and TP53 mutation on the expression of DLL4 in human cancer stem disorderOncotarget2016739629766298827542210
   PubMedGoogle Scholar
• BirchJMHartleyALTrickerKJPrevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni familiesCancer Res1994545129813048118819
   PubMed Web of Science ®Google Scholar
• EelesRAGermline mutations in the TP53 geneCancer Surv1995251011248718514
   PubMedGoogle Scholar
• TinatJBougeardGBaert-DesurmontS2009 version of the Chompret criteria for Li Fraumeni syndromeJ Clin Oncol20092726e108e10919652052
   PubMed Web of Science ®Google Scholar
• MaiPLBestAFPetersJARisks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohortCancer2016122233673368127496084
   PubMed Web of Science ®Google Scholar
• GonzalezKDNoltnerKABuzinCHBeyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutationsJ Clin Oncol20092781250125619204208
   PubMed Web of Science ®Google Scholar
• McBrideKABallingerMLKillickELi-Fraumeni syndrome: cancer risk assessment and clinical managementNat Rev Clin Oncol201411526027124642672
   PubMed Web of Science ®Google Scholar
• BougeardGRenaux-PetelMFlamanJMRevisiting Li-Fraumeni syndrome from TP53 mutation carriersJ Clin Oncol201533212345235226014290
   PubMed Web of Science ®Google Scholar
• NCCN guidelines (version 2.2017)2017 Available from: https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdfAccessed March 2, 2017
   Google Scholar
• JatoiIProschanMARandomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated resultsAm J Clin Oncol200528328929415923803
   PubMed Web of Science ®Google Scholar
• AnampaJMakowerDSparanoJAProgress in adjuvant chemotherapy for breast cancer: an overviewBMC Med20151319526278220
   PubMed Web of Science ®Google Scholar
• KappelSJanschekEWolfBTP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni familyBreast Cancer Res Treat2015151367167825981898
   PubMed Web of Science ®Google Scholar
• LoweSWRuleyHEJacksTHousmanDEp53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell19937469579678402885
   PubMed Web of Science ®Google Scholar
• Kandioler-EckersbergerDLudwigCRudasMTP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patientsClin Cancer Res200061505610656431
   PubMed Web of Science ®Google Scholar
• DarbySMcGalePCorreaCEffect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trialsLancet (London, England)2011378980417071716
   PubMed Web of Science ®Google Scholar
• HeymannSDelalogeSRahalARadio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndromeRadiat Oncol2010510421059199
   PubMed Web of Science ®Google Scholar
• RubinoCde VathaireFShamsaldinALabbeMLeMGRadiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatmentBr J Cancer200389584084612942115
   PubMed Web of Science ®Google Scholar
• HisadaMGarberJEFungCYFraumeniJFJrLiFPMultiple primary cancers in families with Li-Fraumeni syndromeJ Natl Cancer Inst19989086066119554443
   PubMedGoogle Scholar
• LimacherJMFrebourgTNatarajan-AmeSBergeratJPTwo meta-chronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndromeInt J Cancer200196423824211474498
   PubMed Web of Science ®Google Scholar
• LeeJMAbrahamsonJLKandelRDonehowerLABernsteinASusceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient miceOncogene1994912373137367970733
   PubMed Web of Science ®Google Scholar
• KempCJWheldonTBalmainAp53-deficient mice are extremely susceptible to radiation-induced tumorigenesisNat Genet19948166697987394
   PubMed Web of Science ®Google Scholar
• ChadazTHobbsSKSonHChest wall sarcoma: 18F-FDG PET/CT in a patient with Li-Fraumeni syndromeClin Nucl Med2013381081882024107814
   PubMed Web of Science ®Google Scholar
• SalmonAAmikamDSodhaNRapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline ‘de-novo’ TP53 mutationClin Oncol (R Coll Radiol)200719749049317572079
   PubMed Web of Science ®Google Scholar
• MasciariSVan den AbbeeleADDillerLRF18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndromeJAMA2008299111315131918349092
   PubMed Web of Science ®Google Scholar
• MaiPLBaseline cancer screening findings from the NCI Li-Fraumeni syndrome study2016ASCO Annual meeting2016Chicago, IL, USA
   Google Scholar
• VillaniAShoreAWassermanJDBiochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational studyLancet Oncol20161791295130527501770
   PubMed Web of Science ®Google Scholar